EMA — authorised 25 August 1996
- Marketing authorisation holder: AbbVie Deutschland GmbH Co. KG
- Status: approved
EMA authorised Norvir on 25 August 1996
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 25 August 1996.
AbbVie Deutschland GmbH Co. KG holds the EU marketing authorisation.